Nutritional Therapy in Patients With Post-extubation Dysphagia (NCT06511284) | Clinical Trial Compass
RecruitingNot Applicable
Nutritional Therapy in Patients With Post-extubation Dysphagia
Mexico128 participantsStarted 2024-07-01
Plain-language summary
The aim of this study is to evaluate the impact of the prescription of two doses of protein on the amount in kilograms of muscle mass and on the clinical evolution (time until safe swallowing, time until removal of the feeding stoma, number of hospital readmissions, feeding stoma infections, incidence of pneumonia, functionality, number of falls, fractures and mortality) at 6 months after hospital discharge in patients with enteral nutrition due to post-extubation dysphagia.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who required invasive mechanical ventilation during their hospital stay with a diagnosis of post-extubation dysphagia diagnosed by fibroendoscopy evaluation of swallowing (FEES).
* Patients who discharged with a feeding tube.
* Patients with signed informed consent.
Exclusion Criteria:
* Patients with pre-existing dysphagia, or with neurological conditions that can cause dysphagia (e.g. multiple sclerosis, Parkinson's disease, Alzheimer's, myasthenia gravis).
* Patients with chronic kidney disease, defined as a glomerular filtration rate \<60 ml/min.
* Patients discharged with a terminal condition and/or life expectancy of less than 3 months.
* Diagnosis of HIV, upon receiving clinical follow-up by the team of specialists.
What they're measuring
1
Muscle mass changes
Timeframe: From randomization to 6 months
Trial details
NCT IDNCT06511284
SponsorNational Institute of Respiratory Diseases, Mexico